RT Journal Article
SR Electronic
A1 Kuznar, Wayne
T1 Experts Debate Triple Therapy versus Biologics as Treatment for RA
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 18
SP 10
OP 11
DO 10.1177/155989771318002
UL http://mdc.sagepub.com/content/13/18/10.abstract
AB Whether a biologic response modifier or triple disease-modifying antirheumatic drug (DMARD) therapy should be the mainstay of treatment for patients with rheumatoid arthritis (RA) is a subject for debate. This article compares triple conventional DMARD therapy versus biologic agents for the treatment of RA.